Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study.
Danilo Di BonaEustachio NettisElena MinennaAntonella LovecchioDonato PaolinoMaria Cristina NiziMarcello AlbanesiErminia RidoloMaria Filomena CaiaffaLuigi MacchiaPublished in: Allergy (2020)
Keyphrases